• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NYR

NYRADA INC. - Charts / Financials

5.26% ! 20.0¢
Market Cap $42.18M  !

Nyrada Inc is an Australia-based drug development company. The Company focuses on... Nyrada Inc is an Australia-based drug development company. The Company focuses on development of small molecule drugs pertaining to the underlying pathological processes involved in cardiovascular, neurodegenerative and chronic inflammatory diseases. Its drug development programs include a proprotein convertase subtilisin/kexin type nine (PCSK9) inhibitor for the treatment of high blood low-density lipoprotein (LDL)-cholesterol levels in patients poorly responsive to or unable to take statin drugs. It develops a neuroprotectant drug to reduce the impact of long-term disability in patients with ischaemic stroke and traumatic brain injury. The Company also develops a drug to treat pain associated with peripheral nerve damage and autoimmune diseases such as psoriasis.More

refresh Created with Sketch. REFRESH
Day
Open 19.0¢   Day High 20.5¢   Day Low 19.0¢
Daily Volume 1256504
Bids   Sellers
Number Price Volume   Number Price Volume
1 20.0¢ 31147   3 20.5¢ 103141

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
20.0¢
Change
0.010(5.26%)
Mkt cap ! $42.18M
Open High Low Value Volume
19.0¢ 20.5¢ 19.0¢ $248.3K 1.256M

Buyers (Bids)

No. Vol. Price($)
1 31147 20.0¢
 

Sellers (Offers)

Price($) Vol. No.
20.5¢ 103141 3
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.